Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC TrialEva Versteijne, Mustafa Suker, Karin Groothuis et al.|Journal of Clinical Oncology|2020Cited by 1.1k
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trialJony van Hilst, Ferry A.L.M. Eskens, Daniel J. Lips et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 597
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion studyUdai Banerji, Philippe Aftimos, Carla M.L. van Herpen et al.|The Lancet Oncology|2019Cited by 564
Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumoursInge R. Konings, Ferry A.L.M. Eskens|British Journal of Cancer|2010Cited by 22